Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Osteoporos Int

Search In Journal Title:

Abbravation: Osteoporosis International

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1007/bf02981459

Search In DOI:

ISSN

1433-2965

Search In ISSN:
Search In Title Of Papers:

Influence of age and sex steroids on bone density

Authors: K A Ward S R Pye J E Adams S Boonen D Vanderschueren H Borghs J Gaytant E Gielen G Bartfai F F Casanueva J D Finn G Forti A Giwercman T S Han I T Huhtaniemi K Kula F Labrie M E J Lean N Pendleton M Punab A J Silman F C W Wu T W O’Neill The EMAS study group
Publish Date: 2010/10/30
Volume: 22, Issue: 5, Pages: 1513-1523
PDF Link

Abstract

The influence of age and sex steroids on bone density and geometry of the radius was examined in two European Caucasian populations Agerelated change in bone density and geometry was observed In older men bioavailable oestradiol may play a role in the maintenance of cortical and trabecular bone mineral density BMDEuropean Caucasian men aged 40–79 years were recruited from population registers in two centres Manchester UK and Leuven Belgium for participation in the European Male Ageing Study Total testosterone T and oestradiol E2 were measured by mass spectrometry and the free and bioavailable fractions calculated Peripheral quantitative computed tomography was used to scan the radius at distal 4 and midshaft 50 sitesThree hundred thirtynine men from Manchester and 389 from Leuven mean ages 602 and 600 years respectively participated At the 50 radius site there was a significant decrease with age in cortical BMD bone mineral content BMC cortical thickness and muscle area whilst medullary area increased At the 4 radius site trabecular and total volumetric BMD declined with age Increasing bioavailable E2 bioE2 was associated with increased cortical BMD 50 radius site and trabecular BMD 4 radius site in Leuven but not Manchester men This effect was predominantly in those aged 60 years and over In older Leuven men bioavailable testosterone Bio T was linked with increased cortical BMC muscle area and SSI 50 radius site and total area 4 radius siteThere is agerelated change in bone density and geometry at the midshaft radius in middleaged and elderly European men In older men bioE2 may maintain cortical and trabecular BMD BioT may influence bone health through associations with muscle mass and bone areaThe EMAS Study Group Florence Gianni Forti Luisa Petrone Giovanni Corona Leuven Dirk Vanderschueren Steven Boonen Herman Borghs Lodz Krzysztof Kula Jolanta SlowikowskaHilczer Renata WalczakJedrzejowska London Ilpo Huhtaniemi Malmö Aleksander Giwercman Manchester Frederick Wu Alan Silman Terence O’Neill Joseph Finn Philip Steer Abdelouahid Tajar David Lee Stephen Pye Santiago Felipe Casanueva Mary Lage Szeged Gyorgy Bartfai Imre Földesi Imre Fejes Tartu Margus Punab Paul Korrovitz Turku Min JiangOsteoporosis in men is an increasing but underappreciated clinical and public health problem with the lifetime risk of fracture in men at age 50 years estimated at 21 1 As in women increasing age is one of the major determinants of osteoporosis and fracture risk in men Most studies examining changes in bone health with age have focused on “areal” bone mineral density g/cm2 BMDa 2 as measured by dualenergy Xray absorptiometry DXA 3 4 5 6 There are limitations however in assessment of bone health using DXA In particular DXA tends to overestimate BMD in larger and underestimate in smaller bones Furthermore bone strength and susceptibility to fracture is influenced not only by the bone mineral content BMC but also bone shape and mineral distribution and the loading conditions to which the bone is subjected Peripheral quantitative computed tomography pQCT allows assessment of both bone geometry and material properties including volumetric density BMD In contrast to agerelated changes in DXA BMDa in men there are relatively few data concerning change in BMD as assessed by pQCT and bone structure with ageLevels of sex steroids are known to be associated with BMDa as assessed using DXA and also rate of bone loss 7 8 9 10 11 12 13 The contribution of oestradiol E2 to BMD has been reasonably well established but the effect of testosterone T is less clear as are the effects of sex hormones on bone structural parameters Khosla et al 9 14 showed that oestradiol E2 was the most constant predictor of BMD and geometry measured by QCT with the effect being more marked in elderly men as agerelated declines in sex steroids become relevant Similarly in the MINOS cohort E2 was related to DXA BMDa cortical thickness and area 15 There is some evidence to suggest a threshold effect of oestrogen particularly in cortical bone below which the male skeleton may suffer oestrogenrelated bone loss similar to that in the post menopausal female—the threshold level being the median value of bioavailable bio E2 30 pM in older 60 years men 8 14 Testosterone T has been linked with cortical and trabecular BMD 14 16 with conflicting data on effects on bone geometry Some studies have observed an association between testosterone and bone loss in males 13 whilst others have shown little or no effect be it assessing BMDa or increased fracture risk 15 17 18 19 geometric parameters were not reported in these studies


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Development of an electronic medical record based intervention to improve medical care of osteoporosis
  2. Morbidity following lower extremity fractures in men with spinal cord injury
  3. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass
  4. Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women
  5. Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
  6. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis
  7. Oral bisphosphonates and risk of ischemic stroke: a case–control study
  8. The association between serum osteocalcin levels and metabolic syndrome in Koreans
  9. Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff
  10. Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients
  11. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
  12. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review
  13. Genetic analysis of serum osteocalcin and bone mineral in multigenerational Afro-Caribbean families
  14. Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients
  15. Declining incidence of low-trauma knee fractures in elderly women: nationwide statistics in Finland between 1970 and 2006
  16. Changing health behaviors with social marketing
  17. Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga
  18. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis
  19. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older
  20. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
  21. One year outcomes and costs following a vertebral fracture
  22. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
  23. Classification of women with and without hip fracture based on quantitative computed tomography and finite element analysis
  24. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women
  25. Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study
  26. Tracking of size-adjusted bone mineral content and bone area in boys and girls from 10 to 17 years of age
  27. Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over
  28. Age-related hyperkyphosis, independent of spinal osteoporosis, is associated with impaired mobility in older community-dwelling women
  29. Performance of COLIA1 Polymorphism and Bone Turnover Markers to Identify Postmenopausal Women with Prevalent Vertebral Fractures
  30. Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US
  31. Vitamin D status in men with psoriatic arthritis: a case-control study
  32. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate
  33. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™
  34. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture
  35. De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient
  36. Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats
  37. Precision of 18 F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
  38. RETRACTED ARTICLE: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study
  39. Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study
  40. Quantitative ultrasound and fracture risk prediction in non-osteoporotic men and women as defined by WHO criteria
  41. Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
  42. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
  43. Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw: reply to Subramanian and Quek
  44. The Presence and Severity of Vertebral Fractures is Associated with the Presence of Esophageal Hiatal Hernia in Postmenopausal Women
  45. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
  46. Influence of fall related factors and bone strength on fracture risk in the frail elderly
  47. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women
  48. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
  49. Stroke in relation to use of raloxifene and other drugs against osteoporosis
  50. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women
  51. The relationship between low bone mass and metabolic syndrome in Korean women
  52. Effect of high-dose cholecalciferol (vitamin D 3 ) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial
  53. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
  54. Treatment of osteoporosis after alendronate or risedronate
  55. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
  56. Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women
  57. Bone mass following physical activity in young years: a mean 39-year prospective controlled study in men
  58. Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
  59. Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV)
  60. Age-related differences in the activity of arterial mineral deposition and regional bone metabolism: a 18 F-sodium fluoride positron emission tomography study
  61. Copper deficit as a potential pathogenic factor of reduced bone mineral density and severe tooth wear
  62. Has Choosing Wisely® affected rates of dual-energy X-ray absorptiometry use?
  63. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
  64. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures
  65. The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals
  66. Association between osteocalcin and glucose metabolism: a meta-analysis
  67. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study
  68. Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists
  69. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
  70. Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease
  71. Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies
  72. Both resistance and agility training reduce back pain and improve health-related quality of life in older women with low bone mass
  73. Homocysteine and fracture risk in postmenopausal women: the OFELY study
  74. Excess mortality following hip fracture: a systematic epidemiological review
  75. A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density
  76. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
  77. Weight loss and distal forearm fractures in postmenopausal women
  78. Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands
  79. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  80. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  81. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial

Search Result: